Get startedLog in
    Picture of Damora Therapeutics logo

    DMRA — Damora Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    All News

    Brief: Galecto Announces First Patient Dosed In An Investigator-Initiated Phase 2 Trial Of Gb1211 In Combination With Pembrolizumab

    Picture of Damora Therapeutics logoDamora Therapeutics
    01/05/2024 21:03
    May 1 (Reuters) - Galecto Inc  GLTO.O :
    * GALECTO ANNOUNCES FIRST PATIENT DOSED IN AN
INVESTIGATOR-INITIATED PHASE 2 TRIAL OF GB1211 IN COMBINATION
WITH PEMBROLIZUMAB

Source text for Eikon:  ID:nGNX23xHvM 
Further company coverage:  GLTO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Damora Therapeutics

    See all news